David Lebwohl

Companies

• Intellia TherapeuticsEVP, Chief Medical Officer May 5, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA131,192 shares²$1.5M at $11.48Mar 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 1, 2026Granted 9,943 shares of Intellia Therapeutics²
• Jan 5, 2026Sold 11,903 shares at $9.21 of Intellia Therapeutics³
• Mar 1, 2025Granted 43,200 shares of Intellia Therapeutics⁴
• Jan 3, 2025Sold 9,557 shares at $12.18 of Intellia Therapeutics⁵
• Jan 1, 2025Exercised options 3,189 shares of Intellia Therapeutics⁶
• Mar 1, 2024Granted 38,701 shares of Intellia Therapeutics⁷
• Jan 3, 2024Sold 5,843 shares at $29.46 of Intellia Therapeutics⁸
• Jan 1, 2024Exercised options 3,187 shares of Intellia Therapeutics⁹
• Mar 1, 2023Granted 30,674 shares of Intellia Therapeutics¹⁰
• Jan 4, 2023Sold 2,574 shares at $37.21 of Intellia Therapeutics¹¹
• Jan 1, 2023Exercised options 3,187 shares of Intellia Therapeutics¹²
• Mar 1, 2022Granted 13,816 shares of Intellia Therapeutics¹³
• Jan 1, 2022Sold 1,051 shares at $112.24 of Intellia Therapeutics¹³
• Jan 1, 2022Exercised options 3,187 shares of Intellia Therapeutics¹³
• Nov 5, 2021Sold 200 shares at $135.34 of Intellia Therapeutics¹⁴
• Nov 5, 2021Sold 548 shares at $134.07 of Intellia Therapeutics¹⁴
• Nov 5, 2021Sold 452 shares at $132.62 of Intellia Therapeutics¹⁴
• Nov 5, 2021Sold 1,200 shares at $131.71 of Intellia Therapeutics¹⁴
• Nov 5, 2021Exercised options 2,400 shares at $12.62 of Intellia Therapeutics¹⁴
• Oct 14, 2021Sold 250 shares at $130.47 of Intellia Therapeutics¹⁵
• Oct 14, 2021Sold 525 shares at $129.83 of Intellia Therapeutics¹⁵
• Oct 14, 2021Sold 225 shares at $129.01 of Intellia Therapeutics¹⁵
• Oct 14, 2021Sold 849 shares at $127.81 of Intellia Therapeutics¹⁵
• Oct 14, 2021Sold 551 shares at $126.92 of Intellia Therapeutics¹⁵
• Oct 14, 2021Exercised options 2,400 shares at $12.62 of Intellia Therapeutics¹⁵